About 1 result found for searched term "2247614-80-6" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21222 | BIIB091 | BTK |
| The reversible BTK kinase inhibitor BIIB091 is a highly selective phase I clinical candidate compound for multiple sclerosis. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
